• P-ISSN1225-0163
  • E-ISSN2288-8985
  • SCOPUS, ESCI, KCI

Article Detail

Home > Article Detail
  • P-ISSN 1225-0163
  • E-ISSN 2288-8985

Article Contents

    Problem-solving approach for salbutamol analysis by HPLC during pharmaceutical assay

    Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
    2022, v.35 no.5, pp.189-196
    https://doi.org/10.5806/AST.2022.35.5.189
    Aiesheh Gholizadeh-Hashjin (Student Research Committee, Tabriz University of Medical Sciences, Faculty of Pharmacy)
    Hamed Hamishehkar (Drug Applied Research Center, Tabriz University of Medical Sciences)
    Farnaz Monajjemzadeh (Food and Drug Safety Research Center, Tabriz University of Medical Sciences)
    • Downloaded
    • Viewed

    Abstract

    When cationic basic compounds are chromatographed using hydro-organic mobile phase, the presence of anionic free silanols in the silica-based stationary phases results in broad and asymmetrical peaks. The addition of an ionic reagent to the mobile phase prevents analytes from accessing free silanols, improving peak shape. In this study, the chromatographic behavior of salbutamol sulfate as a basic compound was investigated under various conditions, including the use of different columns, mobile phases, and ion-pair reagents such as triethanolamine (TEA) and sodium heptane sulfonate (SHS). The retention and peak shape of chromatograms were both evaluated. The results show that pre-conditioning the column with TEA and including it in the mobile phase can prevent cationic analytes from accessing anionic silanols, resulting in improved peak shape. Furthermore, buffering the mobile phase is an important factor in keeping the pH constant throughout the process. The chosen method was validated in part. This study could be helpful for researchers and analyst to solve such problems with cationic basic components.

    keywords
    salbutamol, HPLC, silanol, triethanolamine


    Reference

    1

    1. S. Carda-Broch, M. C. García-Alvarez-Coque and M. J. Ruiz-Angel, J. Chromatogr A., 20(1559), 112-117 (2018).

    2

    2. N. J. Eggers and C. M. Saint-Joly, J. Liq. Chromatogr., 6(11), 1955-1967 (1983).

    3

    3. J. Köhler, D. Chase, R. Farlee, A. Vega and J. Kirkland, J. Chromatogr A., 352, 275-305 (1986).

    4

    4. A. Mendez, E. Bosch, M. Roses and U. Neue. J. Chromatogr A., 986(1), 33-44 (2003).

    5

    5. P. Rembischevski and A. L. Gemal, J. Liq. Chromatogr. Relat. Technol., 22(9), 1343-1353 (1999).

    6

    6. A. A. Eel-Zaher, M. A. Fouad and E. F. Eelkady, Anal. Chem. Insights., 9(9), 1-7 (2014).

    7

    7. United States Pharmacopeial Convention, The United States Pharmacopeia, USP 42 NF 37, United States (2019).

    8

    8. M. A. Mahrouse and N. T. Lamie, Microchem. J., 147, 691-706 (2019).

    9

    9. Z. Y. Yang, L. Wang and X. Tang, J. Pharm. Biomed. Anal., 49(3), 811-815 (2009).

    10

    10. W. Kaialy, G. P. Martin, M. D. Ticehurst, P. Royall, M. A. Mohammad, J. Murphy and A. Nokhodchi, AAPS J., 13(1), 30-43 (2011).

    11

    11. L. Mälkki and S. Tammilehto, J. Pharm. Biomed. Anal., 11(1), 79-84 (1993).

    12

    12. ICH Guideline, Q2(R1): Validation of Analytical Procedures:Text and Methodology Q2(R1) in ICH Harmonised Tripartite Guideline (2005).

    상단으로 이동

    Analytical Science and Technology